Patents Assigned to Igene Biotechnology, Inc.
  • Publication number: 20120253078
    Abstract: A food supplement for finishing hogs containing astaxanthin is described.
    Type: Application
    Filed: June 17, 2012
    Publication date: October 4, 2012
    Applicant: IGENE BIOTECHNOLOGY, INC.
    Inventors: Patrick Monahan, Stephen Hiu
  • Publication number: 20110130464
    Abstract: A composition of ractopamine and astaxanthin, included as additives in a feed, for finishing hogs, improves carcass performance.
    Type: Application
    Filed: July 20, 2009
    Publication date: June 2, 2011
    Applicant: IGENE BIOTECHNOLOGY, INC.
    Inventors: Patrick Monahan, Stephen Hiu
  • Publication number: 20100240766
    Abstract: A food supplement for finishing hogs containing astaxanthin is described.
    Type: Application
    Filed: November 6, 2008
    Publication date: September 23, 2010
    Applicant: IGENE BIOTECHNOLOGY, INC.
    Inventors: Patrick Monahan, Stephen Hiu
  • Patent number: 7723066
    Abstract: An economical process for in vivo production of the pigment astaxanthin, and particularly a process for enhancing astaxanthin content of cultures of microorganisms of genus Phaffia, the process comprising culturing a microorganism of genus Phaffia in a nutrient medium containing an antibiotic, a cytochrome B inhibitor, or a terpenoid synthetic pathway inhibitor, cultivating surviving pigment enhanced microorganisms, and harvesting the yeast.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: May 25, 2010
    Assignee: Igene Biotechnology, Inc.
    Inventors: Eric A. Johnson, Huei-hsiung Yang, Beril Geldiay-Tuncer, William T. Hall, David Schreiber, Kwok Ho
  • Patent number: 5356809
    Abstract: An economical process for in vivo production of the pigment astaxanthin, and particularly a process for enhancing astaxanthin content of cultures of microorganisms of genus Phaffia, the process comprising culturing a microorganism of genus Phaffia in a nutrient medium containing an antibiotic, a cytochrome B inhibitor, or a terpenoid synthetic pathway inhibitor, cultivating surviving pigment enhanced microorganisms, and harvesting the yeast.
    Type: Grant
    Filed: February 14, 1992
    Date of Patent: October 18, 1994
    Assignee: Igene Biotechnology, Inc.
    Inventors: Eric A. Johnson, Huei-hsiung Yang, Beril Geldiay-Tuncer, William T. Hall, David Schreiber, Kwok Ho
  • Patent number: 5182208
    Abstract: An economical process for in vivo production of the pigment astaxanthin, and particularly a process for enhancing astaxanthin content of cultures of microorganisms of genus Phaffia, the process comprising culturing a microorganism of genus Phaffia in a nutrient medium containing an antibiotic, a cytochrome B inhibitor, or a terpenoid synthetic pathway inhibitor, cultivating surviving pigment enhanced microorganisms, and harvesting the yeast.
    Type: Grant
    Filed: August 23, 1989
    Date of Patent: January 26, 1993
    Assignee: Igene Biotechnology, Inc.
    Inventors: Eric A. Johnson, David Schreiber, Kwok P. Ho, William T. Hall, Huei-hsiung Yang, Beril Geldiay-Tuncer
  • Patent number: 5057141
    Abstract: Soybean meal and urea compositions have been found to exhibit enhanced and commercially useful nematistatic and nematicidal activity in soils. Chitin-containing materials, e.g., crab shells, shrimp shells, fungal mycella, etc., have also been found to exhibit enhanced and commercially useful nematistatic and nematicidal activity in soils when admixed with other organic nitrogen-containing materials such as ammonium phosphates, a source of urea, and plant, fish or animal meal. Also, compositions formulated of two different chitin source materials can be used. The soybean-urea compositions as well as the blended chitin-containing formulations are non-phytotoxic and simultaneously provide cost-effective biological suppression of plant pathogenic nematode populations and excellent plant nutrition.
    Type: Grant
    Filed: August 1, 1988
    Date of Patent: October 15, 1991
    Assignee: Igene Biotechnology Inc.
    Inventors: R. Rodriquez-Kabana, Robert A. Milch
  • Patent number: 4859597
    Abstract: A method for producing a lysin-free phage inoculum, which comprises:(a) inoculating a growing Streptococcal culture with phage,(b) incubating the culture for a plurality of lytic cycles of phage until the cells are completely lysed to obtain a lysate, and(c) removing cell debris and free lysin from the lysate to form a lysin-free phage suitable for use as an inoculum.A method for producing lysin is also disclosed.
    Type: Grant
    Filed: July 27, 1987
    Date of Patent: August 22, 1989
    Assignee: Igene Biotechnology, Inc.
    Inventors: Huei-Hsiung Yang, Stephen F. Hiu, John L. Harris
  • Patent number: 4794080
    Abstract: A simultaneous sequential anaerobic fermentation process for the in vitro production of propionic and acetic acids is disclosed. The process comprises employing an obligatory two-component co-culture which maintains a relatively constant ratio of species populations over multiple passages. A first co-culture component is a Lactobacillus or Streptococcus which homofermentatively converts the hexose to lactic acid. A second microorganism in the co-culture is a Veillonella which is metabolically incapable of assimillating the hexose and converts the lactic acid product to propionic and acetic acids. The co-culture is inoculated into a nutrient growth feedstock such as whole whey or a clarified dairy whey lactose permeate which contains a metabolizable source of a hexose such as glucose, lactose or sucrose.
    Type: Grant
    Filed: April 16, 1984
    Date of Patent: December 27, 1988
    Assignee: IGENE Biotechnology, Inc.
    Inventors: Thomas D. Mays, Pamela N. Fornili
  • Patent number: 4769254
    Abstract: A water-soluble levan having a weight average molecular weight of about 10,000-40 million, preferably about 5-25 million and especially about 10-20 million which stabilizes a bovine serum albumin colloid having index (EAI) of about 3-100 determined according to the formula EAI=2T/OC wherein T is turbidity measured at 500 nm, C is the weight of emulsified protein per unit volume of the aqueous phase, and O is the volume fraction of a dispersed oil phase is produced by fermenting a nutrient growth medium feedstock having a carbon source consisting essentially of an assimilable sugar selected from the group consisting of sucrose, raffinose, or a mixture thereof with a microorganism capable of converting at least 50%. of the fructose value of the sugar to said levan under nutrient growth conditions which enhance levan production while suppressing ethanol production. It is useful as a colloid stabilizing agent, particularly with foods, beverages, pharmaceuticals, dentifrices, and cosmetics.
    Type: Grant
    Filed: September 26, 1985
    Date of Patent: September 6, 1988
    Assignee: Igene Biotechnology, Inc.
    Inventors: Thomas D. Mays, Ellen L. Dally
  • Patent number: 4670251
    Abstract: A solid pharmaceutical composition suitable for oral or rectal administration comprising a unit dosage of a pharmaceutically active ingredient (and optionally one or more inert fillers) homogeneously dispersed in a pharmaceutically acceptable binder, wherein at least a major portion (i.e., at least 50% by weight) of the binder is a microcrystalline solid phase prepared by raising the pH of a dairy whey lactose permeate having a pH below about 7 to a pH between about 8 and 10 to form (i) a lactose-rich aqueous solute phase capable of being autoclaved for 10-20 minutes at 121.degree. C.
    Type: Grant
    Filed: September 20, 1984
    Date of Patent: June 2, 1987
    Assignee: Igene Biotechnology, Inc.
    Inventor: John F. Blanco